Terazosin Hydrochloride
Product Images NDC 71610-762

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 71610-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0762 60)

Terazosin Hydrochloride 10 mg capsules carton with 90 capsules, labeled Terazosin, USP. The label includes storage instructions, packaging information as blister card (BYS: GSMs, Inc.), and the labeler is Aphena Pharma Solutions - Tennessee, LLC located in Cookeville, TN. The product NDC is 71610-0762-60.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosinhydrochloridechemicalstructure (Chemicalstructure)

Chemical structure diagram of Terazosin Hydrochloride, showing its molecular framework including functional groups such as methoxy, amino, piperazine, carbamate, and tetrahydrofuran rings, along with a hydrochloride salt.*

FDA Label Image

Figure1 (Figure1)

Two line graphs comparing Terazosin and placebo groups over three months. The left graph shows mean change in total symptom score from baseline, with Terazosin decreasing symptoms more significantly than placebo. The right graph depicts mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing a greater increase than placebo. Both graphs include data points with error bars and sample sizes.*

FDA Label Image

Figure2 (Figure2)

A line chart depicting the mean change from baseline over a 30-month period. The x-axis represents time in months (0 to 30), and the y-axis shows the mean change values. The graph illustrates an initial steep decline followed by a gradual stabilization with data points marked by circles and statistically significant points indicated by asterisks.*

FDA Label Image

Figure3 (Figure3)

A line graph showing the mean change from baseline in mL/sec over a 30-month period. The x-axis represents time in months, from 0 to 30, and the y-axis shows the mean change ranging from 0 to 4.5 mL/sec. Data points indicate measurements at various months with some marked by asterisks, representing statistically significant differences at certain time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.